Study of AT-752 in Patients With Dengue Infection

PHASE2TerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 29, 2022

Primary Completion Date

January 19, 2023

Study Completion Date

January 19, 2023

Conditions
Dengue Fever
Interventions
DRUG

AT-752

AT-752 for 5 days

DRUG

Placebo

Placebo for 5 days

Trial Locations (32)

Unknown

Atea Study Site, Belo Horizonte

Atea Study Site, Campo Grande

Atea Study Site, Cuiabá

Atea Study Site, Manaus

Atea Study Site, Natal

Atea Study Site, Porto Velho

Atea Study Site, Recife

Atea Study Site, Ribeirão Preto

Atea Study Site, Rio de Janeiro

Atea Study Site, São José do Rio Preto

Atea Study Site, São Paulo

Atea Study Site, Aguazul

Atea Study Site, Antioquia

Atea Study Site, Girardot

Atea Study Site, Santiago de Cali

Atea Study Site, Yopal

Atea Study Site, Machala

Atea Study Site, Guwahati

Atea Study Site, Kanpur

Atea Study Site, Lucknow

Atea Study Site, Sūrat

Atea Study Site, Kuala Terengganu

Atea Study Site, Perai

Atea Study Site, Ica

Atea Study Site, Iquitos

Atea Study Site, Iloilo City

Atea Study Site, Las Piñas

Atea Study Site, Quezon City

Atea Study Site, Kaohsiung City

Atea Study Site, Bangkok

Atea Study Site, Khon Kaen

Atea Study Site, Hanoi

Sponsors
All Listed Sponsors
lead

Atea Pharmaceuticals, Inc.

INDUSTRY